
Transcatheter Aortic Valve Replacement (TAVR) Industry Research Report 2024
Description
Transcatheter Aortic Valve Replacement (TAVR) Industry Research Report 2024
Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place.
According to APO Research, The global Transcatheter Aortic Valve Replacement (TAVR) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
In China, Transcatheter Aortic Valve Replacement (TAVR) key players include Venus Medtech, Suzhou Jiecheng Medical Technology Co., Peijia Medical, etc.
East China is the largest consumer region of transcatheter aortic valve replacement in China, followed by North and South China.
In terms of product, Transfemoral Approach is the largest segment, with a share over 80%. And in terms of application, the largest application is Aortic Stenosis, followed by Aortic Regurgitation.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Transcatheter Aortic Valve Replacement (TAVR), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transcatheter Aortic Valve Replacement (TAVR).
The Transcatheter Aortic Valve Replacement (TAVR) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transcatheter Aortic Valve Replacement (TAVR) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Edwards Lifesciences
Medtronic
Abbott
Boston Scientific
Meril Life Sciences
Venus Medtech
Bracco (HLT)
JenaValve Technology
Suzhou Jiecheng Medical Technology Co.
Peijia Medical
Transcatheter Aortic Valve Replacement (TAVR) segment by Type
Transfemoral Approach
Transapical Approach
Others
Transcatheter Aortic Valve Replacement (TAVR) Segment by Application
Aortic Stenosis
Aortic Regurgitation
Others
Transcatheter Aortic Valve Replacement (TAVR) Segment by Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transcatheter Aortic Valve Replacement (TAVR) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transcatheter Aortic Valve Replacement (TAVR) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transcatheter Aortic Valve Replacement (TAVR).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Transcatheter Aortic Valve Replacement (TAVR) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Chapter 13: The main points and conclusions of the report.
Table of Contents
115 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Transcatheter Aortic Valve Replacement (TAVR) by Type
- 2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
- 2.2.2 Transfemoral Approach
- 2.2.3 Transapical Approach
- 2.2.4 Others
- 2.3 Transcatheter Aortic Valve Replacement (TAVR) by Application
- 2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
- 2.3.2 Aortic Stenosis
- 2.3.3 Aortic Regurgitation
- 2.3.4 Others
- 2.4 Assumptions and Limitations
- 3 Transcatheter Aortic Valve Replacement (TAVR) Breakdown Data by Type
- 3.1 Global Transcatheter Aortic Valve Replacement (TAVR) Historic Market Size by Type (2019-2024)
- 3.2 Global Transcatheter Aortic Valve Replacement (TAVR) Forecasted Market Size by Type (2025-2030)
- 4 Transcatheter Aortic Valve Replacement (TAVR) Breakdown Data by Application
- 4.1 Global Transcatheter Aortic Valve Replacement (TAVR) Historic Market Size by Application (2019-2024)
- 4.2 Global Transcatheter Aortic Valve Replacement (TAVR) Forecasted Market Size by Application (2019-2024)
- 5 Global Growth Trends
- 5.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market Perspective (2019-2030)
- 5.2 Global Transcatheter Aortic Valve Replacement (TAVR) Growth Trends by Region
- 5.2.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Region: 2019 VS 2023 VS 2030
- 5.2.2 Transcatheter Aortic Valve Replacement (TAVR) Historic Market Size by Region (2019-2024)
- 5.2.3 Transcatheter Aortic Valve Replacement (TAVR) Forecasted Market Size by Region (2025-2030)
- 5.3 Transcatheter Aortic Valve Replacement (TAVR) Market Dynamics
- 5.3.1 Transcatheter Aortic Valve Replacement (TAVR) Industry Trends
- 5.3.2 Transcatheter Aortic Valve Replacement (TAVR) Market Drivers
- 5.3.3 Transcatheter Aortic Valve Replacement (TAVR) Market Challenges
- 5.3.4 Transcatheter Aortic Valve Replacement (TAVR) Market Restraints
- 6 Market Competitive Landscape by Players
- 6.1 Global Top Transcatheter Aortic Valve Replacement (TAVR) Players by Revenue
- 6.1.1 Global Top Transcatheter Aortic Valve Replacement (TAVR) Players by Revenue (2019-2024)
- 6.1.2 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Players (2019-2024)
- 6.2 Global Transcatheter Aortic Valve Replacement (TAVR) Industry Players Ranking, 2022 VS 2023 VS 2024
- 6.3 Global Key Players of Transcatheter Aortic Valve Replacement (TAVR) Head office and Area Served
- 6.4 Global Transcatheter Aortic Valve Replacement (TAVR) Players, Product Type & Application
- 6.5 Global Transcatheter Aortic Valve Replacement (TAVR) Players, Date of Enter into This Industry
- 6.6 Global Transcatheter Aortic Valve Replacement (TAVR) Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
- 7 North America
- 7.1 North America Transcatheter Aortic Valve Replacement (TAVR) Market Size (2019-2030)
- 7.2 North America Transcatheter Aortic Valve Replacement (TAVR) Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 7.3 North America Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country (2019-2024)
- 7.4 North America Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country (2025-2030)
- 7.5 United States
- 7.6 Canada
- 8 Europe
- 8.1 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Size (2019-2030)
- 8.2 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 8.3 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country (2019-2024)
- 8.4 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country (2025-2030)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Russia
- 8.10 Nordic Countries
- 9 Asia-Pacific
- 9.1 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Market Size (2019-2030)
- 9.2 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 9.3 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country (2019-2024)
- 9.4 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country (2025-2030)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 Southeast Asia
- 9.9 India
- 9.10 Australia
- 10 Latin America
- 10.1 Latin America Transcatheter Aortic Valve Replacement (TAVR) Market Size (2019-2030)
- 10.2 Latin America Transcatheter Aortic Valve Replacement (TAVR) Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 10.3 Latin America Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country (2019-2024)
- 10.4 Latin America Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country (2025-2030)
- 10.5 Mexico
- 10.6 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Transcatheter Aortic Valve Replacement (TAVR) Market Size (2019-2030)
- 11.2 Middle East & Africa Transcatheter Aortic Valve Replacement (TAVR) Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 11.3 Middle East & Africa Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country (2019-2024)
- 11.4 Middle East & Africa Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country (2025-2030)
- 11.5 Turkey
- 11.6 Saudi Arabia
- 11.7 UAE
- 12 Players Profiled
- 12.1 Edwards Lifesciences
- 12.1.1 Edwards Lifesciences Company Information
- 12.1.2 Edwards Lifesciences Business Overview
- 12.1.3 Edwards Lifesciences Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2019-2024)
- 12.1.4 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 12.1.5 Edwards Lifesciences Recent Developments
- 12.2 Medtronic
- 12.2.1 Medtronic Company Information
- 12.2.2 Medtronic Business Overview
- 12.2.3 Medtronic Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2019-2024)
- 12.2.4 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 12.2.5 Medtronic Recent Developments
- 12.3 Abbott
- 12.3.1 Abbott Company Information
- 12.3.2 Abbott Business Overview
- 12.3.3 Abbott Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2019-2024)
- 12.3.4 Abbott Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 12.3.5 Abbott Recent Developments
- 12.4 Boston Scientific
- 12.4.1 Boston Scientific Company Information
- 12.4.2 Boston Scientific Business Overview
- 12.4.3 Boston Scientific Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2019-2024)
- 12.4.4 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 12.4.5 Boston Scientific Recent Developments
- 12.5 Meril Life Sciences
- 12.5.1 Meril Life Sciences Company Information
- 12.5.2 Meril Life Sciences Business Overview
- 12.5.3 Meril Life Sciences Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2019-2024)
- 12.5.4 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 12.5.5 Meril Life Sciences Recent Developments
- 12.6 Venus Medtech
- 12.6.1 Venus Medtech Company Information
- 12.6.2 Venus Medtech Business Overview
- 12.6.3 Venus Medtech Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2019-2024)
- 12.6.4 Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 12.6.5 Venus Medtech Recent Developments
- 12.7 Bracco (HLT)
- 12.7.1 Bracco (HLT) Company Information
- 12.7.2 Bracco (HLT) Business Overview
- 12.7.3 Bracco (HLT) Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2019-2024)
- 12.7.4 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 12.7.5 Bracco (HLT) Recent Developments
- 12.8 JenaValve Technology
- 12.8.1 JenaValve Technology Company Information
- 12.8.2 JenaValve Technology Business Overview
- 12.8.3 JenaValve Technology Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2019-2024)
- 12.8.4 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 12.8.5 JenaValve Technology Recent Developments
- 12.9 Suzhou Jiecheng Medical Technology Co.
- 12.9.1 Suzhou Jiecheng Medical Technology Co. Company Information
- 12.9.2 Suzhou Jiecheng Medical Technology Co. Business Overview
- 12.9.3 Suzhou Jiecheng Medical Technology Co. Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2019-2024)
- 12.9.4 Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 12.9.5 Suzhou Jiecheng Medical Technology Co. Recent Developments
- 12.10 Peijia Medical
- 12.10.1 Peijia Medical Company Information
- 12.10.2 Peijia Medical Business Overview
- 12.10.3 Peijia Medical Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2019-2024)
- 12.10.4 Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 12.10.5 Peijia Medical Recent Developments
- 13 Report Conclusion
- 14 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.